Contineum Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need. Contineum targets biological pathways associated with specific clinical disabilities, that once modulated, can demonstrably impact the course of disease. 

Biotechnology

Life Sciences

Neuroscience

Pharmaceutical

Therapeutics

Contineum Therapeutics

Contineum Therapeutics' headquarters in San Diego, United States

Carmine Stengone

Daniel S. Lorrain

Julie Iwashita

Jennifer Patterson

Josh R.

Varsha Dourado

Peter Slover

The Leadership Team at Contineum Therapeutics is responsible for setting the strategic direction and overseeing the operational execution of the company's initiatives. This team ensures the successful discovery, development, and commercialization of novel therapies by leveraging their expertise in finance, clinical operations, business development, and scientific research. The Leadership Team also plays a critical role in securing funding, regulatory compliance, and fostering strategic partnerships to address high unmet needs in neuroscience, inflammation, and immunology.

Leadership Team

The Clinical Operations Team at Contineum Therapeutics is responsible for planning, managing, and executing clinical trials to evaluate the safety and efficacy of novel small molecule therapies targeting neuroscience, inflammation, and immunology indications. This team ensures compliance with regulatory requirements, optimizes trial design, and oversees site selection and patient recruitment to advance drug candidates through the clinical development pipeline.

Contineum Therapeutics

Org chart

Teams

Leadership Team

Clinical Operations Team

Offices

Contineum Therapeutics

Org chart

Teams

Leadership Team

Clinical Operations Team

Offices

Related companies